Microembolism
(Unterschied zwischen Versionen)
(Die Seite wurde neu angelegt: „{{ttp|p=32369610|t=2020. Severe COVID-19 infe{{tp|p=32333579|t=2020. (clin-hemorheol-microcirc) COVID-19 |pdf=|usr=}} {{ttp|p=32294809|t=2020. Microvascular CO…“) |
K |
||
| Zeile 1: | Zeile 1: | ||
| − | {{ | + | {{tp|p=32369610|t=2020. Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily |pdf=|usr=}} |
| + | {{tp|p=32333579|t=2020. (clin-hemorheol-microcirc) COVID-19 |pdf=|usr=}} | ||
{{ttp|p=32294809|t=2020. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis |pdf=|usr=}} | {{ttp|p=32294809|t=2020. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis |pdf=|usr=}} | ||
{{ttp|p=32403033|t=2020. Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid |pdf=|usr=}} | {{ttp|p=32403033|t=2020. Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid |pdf=|usr=}} | ||
Version vom 12. Juni 2020, 11:42 Uhr
32369610 2020. Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily
32333579 2020. (clin-hemorheol-microcirc) COVID-19
| 32294809 2020. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis |
| 32403033 2020. Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid |
